Targeting CD83 in mantle cell lymphoma with anti-human CD83 antibody

Clinical & Translational Immunology
Ziduo LiGeorgina J Clark

Abstract

Effective antibody-drug conjugates (ADCs) provide potent targeted cancer therapies. CD83 is expressed on activated immune cells including B cells and is a therapeutic target for Hodgkin lymphoma. Our objective was to determine CD83 expression on non-Hodgkin lymphoma (NHL) and its therapeutic potential to treat mantle cell lymphoma (MCL) which is currently an incurable NHL. We analysed CD83 expression on MCL cell lines and the lymph node/bone marrow biopsies of MCL patients. We tested the killing effect of CD83 ADC in vitro and in an in vivo xenograft MCL mouse model. CD83 is expressed on MCL, and its upregulation is correlated with the nuclear factor κB (NF-κB) activation. CD83 ADC kills MCL in vitro and in vivo. Doxorubicin and cyclophosphamide (CP), which are included in the current treatment regimen for MCL, enhance the NF-κB activity and increase CD83 expression on MCL cell lines. The combination of CD83 ADC with doxorubicin and CP has synergistic killing effect of MCL. This study provides evidence that a novel immunotherapeutic agent CD83 ADC, in combination with chemotherapy, has the potential to enhance the efficacy of current treatments for MCL.

References

Oct 27, 2001·The Journal of Biological Chemistry·X BianA W Opipari
Aug 17, 2002·Immunobiology·Susanne BerchtoldAlexander Steinkasserer
Jul 15, 2003·Journal of Virology·Diana DudziakGeorg W Bornkamm
Apr 1, 2004·Molecular Cell·Kirsteen J CampbellNeil D Perkins
Feb 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dejan JuricBranimir I Sikic
Dec 18, 2007·Leukemia Research·Philipp BaumannRalf Schmidmaier
Feb 29, 2008·Proceedings of the National Academy of Sciences of the United States of America·Aude De GassartEvelina Gatti
Mar 8, 2008·Science·Georg LenzLouis M Staudt
May 9, 2008·Leukemia & Lymphoma·Minh Quang HuynhAndreas Neubauer
Jun 3, 2008·Molecular Immunology·R B Baleeiro, J A M Barbuto
Jul 16, 2008·Radiologic Clinics of North America·Matthew J Matasar, Andrew D Zelenetz
Nov 5, 2010·The New England Journal of Medicine·Anas YounesAndres Forero-Torres
Jan 17, 2012·Leukemia & Lymphoma·Rekha ChandranStephen E Spurgeon
Oct 10, 2012·Annual Review of Medicine·Eric L Sievers, Peter D Senter
Nov 8, 2012·Oncotarget·Alireza Hadj KhodabakhshiSteven J M Jones
Jun 21, 2013·The New England Journal of Medicine·Michael L WangKristie A Blum
Oct 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sílvia BeàElías Campo
Dec 17, 2014·Blood·Elias Campo, Simon Rule
Jan 13, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chan Yoon CheahMichael L Wang
Mar 18, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lena KrzyzakLars Nitschke
Jun 14, 2016·The New England Journal of Medicine·Hagop M KantarjianAnjali S Advani
Oct 27, 2016·Molecular Cancer Therapeutics·Frank LoganzoHans-Peter Gerber
Nov 12, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xinsheng JuDerek N J Hart
Jun 17, 2018·Journal of Hematology & Oncology·Swathi BalajiMichael Wang
Feb 9, 2019·Experimental Hematology & Oncology·Abdullah LadhaJeffrey J Pu
Jun 25, 2019·Frontiers in Immunology·Ziduo LiGeorgina J Clark

❮ Previous
Next ❯

Citations

Jul 15, 2021·Experimental Hematology & Oncology·Panruo JiangHaige Ye

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
flow cytometry
PCR
xenograft
biopsy
Protein Assay
Flow

Clinical Trials Mentioned

NCT02669017
NCT03424603

Software Mentioned

Prism
FlowJo
GraphPad
Image Lab

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

The Journal of Immunology : Official Journal of the American Association of Immunologists
Xinsheng JuDerek N J Hart
The Journal of Immunology : Official Journal of the American Association of Immunologists
D DudziakGerhard Laux
International Archives of Allergy and Immunology
M LechmannA Steinkasserer
The Journal of Immunology : Official Journal of the American Association of Immunologists
Charlene M PrazmaT F Tedder
© 2021 Meta ULC. All rights reserved